| The global burden of asthma: executive summary of the GINA Dissemination Committee report M Masoli, D Fabian, S Holt, R Beasley, ... Allergy 59 (5), 469-478, 2004 | 5674 | 2004 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2044* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 448* | 2021 |
| Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The Lancet Respiratory Medicine 7 (1), 46-59, 2019 | 292 | 2019 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 240 | 2022 |
| Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma M Masoli, M Weatherall, S Holt, R Beasley Thorax 60 (9), 730-734, 2005 | 163 | 2005 |
| A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales ME Hyland, B Whalley, RC Jones, M Masoli Quality of Life Research 24, 631-639, 2015 | 149 | 2015 |
| Long-term safety and clinical benefit of mepolizumab in patients with the most severe eosinophilic asthma: the COSMEX study S Khurana, GG Brusselle, EH Bel, JM FitzGerald, M Masoli, S Korn, ... Clinical therapeutics 41 (10), 2041-2056. e5, 2019 | 147 | 2019 |
| Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial R Hughes, A Goldkorn, M Masoli, M Weatherall, C Burgess, R Beasley The Lancet 361 (9375), 2114-2117, 2003 | 145 | 2003 |
| Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis M Masoli, S Holt, M Weatherall, R Beasley European Respiratory Journal 23 (4), 552-558, 2004 | 118 | 2004 |
| Clinical dose-response relationship of fluticasone propionate in adults with asthma M Masoli, M Weatherall, S Holt, R Beasley Thorax 59 (1), 16-20, 2004 | 116 | 2004 |
| Global burden of asthma. Developed for the Global Initiative for Asthma (GINA) M Masoli, D Fabian, S Holt, R Beasley Allergy 59, 469-478, 2004 | 114 | 2004 |
| Defining a severe asthma super-responder: findings from a Delphi process JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021 | 101 | 2021 |
| Dose–response relationship for risk of non‐vertebral fracture with inhaled corticosteroids M Weatherall, K James, J Clay, K Perrin, M Masoli, M Wijesinghe, ... Clinical & Experimental Allergy 38 (9), 1451-1458, 2008 | 101 | 2008 |
| Building bridges for innovation in ageing: synergies between action groups of the EIP on AHA J Bousquet, M Bewick, A Cano, P Eklund, G Fico, N Goswami, ... The journal of nutrition, health & aging 21, 92-104, 2017 | 90 | 2017 |
| Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study) RM Niven, D Saralaya, R Chaudhuri, M Masoli, I Clifton, AH Mansur, ... BMJ open 6 (8), e011857, 2016 | 80 | 2016 |
| Global burden of asthma M Masoli http://www. ginasthma. com, 2003 | 73 | 2003 |
| Systematic review of the dose-response relation of inhaled fluticasone propionate M Masoli, M Weatherall, S Holt, R Beasley Archives of disease in childhood 89 (10), 902-907, 2004 | 67 | 2004 |
| Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis M Masoli, M Weatherall, S Holt, P Shirtcliffe, R Beasley European Respiratory Journal 28 (5), 960-967, 2006 | 57 | 2006 |
| Budesonide once versus twice‐daily administration: meta‐analysis M Masoli, M Weatherall, S Holt, R Beasley Respirology 9 (4), 528-534, 2004 | 55 | 2004 |
